Promo Code (if applicable) ... mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.
|
|
- Austen Matthew Dorsey
- 5 years ago
- Views:
Transcription
1 Genetic Diagnostics A. Analysis Requested 1. Test(s)/Gene(s) 1.1 Single Gene Sequencing 1.2 NGS Panel 1.3 NGS Panel Plus 1.4 NGS Panel Genomic 1.5 Deletion/Duplication Analysis 1.6 Repeat Expansion 1.7 Hotspot Testing 1.8 Carrier Testing Promo Code (if applicable)... mutation description 2. Specific Request: 2.1 Prenatal Diagnosis (additional fee applies) (please contact us prior sample shipment) *Prenatal testing is currently not offered in the US CentoArrayCyto HD CentoArrayCyto 750K B. Patient Name (Label) 1. Surname C. Sender (Reporting Address) 1. Name of Physician 2. First Name 3. Date of Birth M M D D Y Y Y Y 4. Sex 4.1 Male 4.2 Female 5. Street 6. Zip Code / Town 7. Country 8. Your Reference Number 9. Sample Date M M D D Y Y Y Y D. Second Reporting Address (if applicable) 1. Name of Physician 2. Clinic 3. Department 4. Street 5. Zip Code / Town 6. Country 7. Telephone 8. Fax Clinic 3. Department 4. Street 5. Zip Code / Town 6. Country 7. Telephone 8. Fax 9. Please note that all diagnostic reports are exclusively available via our online CentoPortal Additional report recipient(s) can be conveniently added for individual requests via the portal. E. Billing 1. CENTOGENE Quotation No. 2. Invoice to 2.1 Patient 2.2 Clinic/Insurance Please attach authorization/referral 3. Name 4. Department 5. Street 6. ZIP Code / Town 7. Country Genetic Testing for Metabolic Diseases I herewith confirm the correctness of the above given information. Place, Date Signature of Physician 8. VAT No. 9. Telephone 10. Fax 11. The Terms & Conditions of CENTOGENE AG, which are available on apply to your order. Your specific order will be invoiced at the specific prices as listed on at the time of receipt of your order. To add clinical or additional information please use page 5 We need mandatorily the following pages from you: 1-5 All offered testing results are supported by CentoMD In Case of Direct Billing to the Patient I authorize the physician to request this analysis/these analyses and I am informed about the resulting costs (and possibly applicable German 19% VAT). I herewith undertake to be liable for the payment of any invoice related to this diagnostics and I declare that the address given above is the correct billing address. Place, Date Signature of Patient/Guardian Material Requirements EDTA Blood (2 ml single gene / 10 ml for panels) Filtercards (1 pc. [10 spots], more filtercards for complex genes) Filtercards are available on request from CENTOGENE. Purified DNA (1-10 µg single gene / µg for panels) Tissue (FFPE mg) Amniotic Fluid (10 ml) CVS / Chorionic Villus (10 villi, cleaned) Fibroblast / Skin Biopsy (0.5 cm2) Snap Frozen Affected Tissue (~50mg) Saliva (Oragene OG-510) Kits are available on request from CENTOGENE. Other: For detailed material requirements, please refer to page 17. CLIA #99D ACCREDITED Page 1
2 Consent form for conducting genetic analyses It is mandatory to ensure that a patient has signed his or her consent to conduct genetic analyses. This can be given either by: Part (I): Signed consent on the part of the patient OR Part (II): Signed confirmation on the part of the physician stating that the signed patient consent exists in the files CENTOGENE needs either Part (I) OR (II) in order to be legally able to conduct genetic analysis. Please ensure that the applicable document accompanies the sample(s). Dear patient, Your physician has recommended for you (or a person for whom you have custody and you care for) a genetic analysis to clarify the following diagnosis/symptoms: It is also not possible to exclude every disease risk for yourself and your family members (especially your children) utilizing genetic analyses. The knowledge of the results may result in mental stress. It is always recommended to discuss the details of the genetic report with your local doctor. Information (to be completed by physician) We would like to explain the purpose of these analyses, what occurs with a genetic test and the importance the results could have for you and your family. For more specific information on the genetic test, please refer to the requisition form. The purpose of a genetic test is to study your genetic material (DNA) using a molecular-genetic method that has the capability to detect the disease that has occurred or is suspected in you or your family based on changes (called mutations). In a genetic analysis depending on the case either individual genetic characteristics for a specific condition or many genetic characteristics are investigated at the same time using an overview method (e.g. using exome or genome sequencing). The study material that is used for your genetic test is stated in the requisition form and is typically blood. Incidental findings: In principle, results can occur for all testing techniques that are not directly related to the actual issue but may still be of medical importance for you and your family (so-called incidental findings). In particular for the overview methods such as genome sequencing, incidental results can occur that relate to higher risks (that you may not be aware of ) for potentially serious, unavoidable or non-treatable diseases. As part of the consent you can decide whether and under what circumstances you wish to be informed about such incidental findings. Family findings: If several family members are tested, a correct interpretation of the results depends on the assumed relationships being correct. If doubt is created by the genetic analysis about the apparent relationships, we will not inform you. An exception will be made if it is absolutely necessary for the completion of the requested test. Use of the sample/results: The sample and the test results will be used for the analysis and in accordance with your consent declaration that is stated below. The test results will also be used - if possible - for treatment decisions by your physician(s). Information Significance of the results: If a characteristic result in a disease is demonstrated, this result is usually highly conclusive. If no disease-causing mutation is found, genetic changes responsible for the disease may still exist. A genetic disease or tendency to have a disease can therefore not usually be fully excluded. Sometimes gene variants are proven but their significance is not clear. This is stated in the results and discussed with you. A comprehensive explanation of all possible causes of diseases due to genetic reasons is not possible. Right of revocation: You can withdraw your consent to the analysis/examination with effect for the future at any time in full or in part without stating reasons. Right not to know: You have the right not to be informed about test results (right not to know), to stop the testing processes that have been started at any time up to being given the results and to request the destruction of all test/examination results not already known to you. Page 2 Page 1 V6.1eng_Information_November2017
3 Part (I): Declaration of consent (please read this carefully) Patient Copy By signing this declaration of consent I acknowledge that I have received, read and understood the preceding written explanation of genetic analyses and the further explanation contained in the requisition form; I have received appropriate explanations (from my physician) with regard to the disease: (to be filled in by the physician) the genetic basis, the purpose, scope, type and significance of the planned genetic test(s), achievable results by the planned test, the importance of the analyzed genetic characteristics for my disease/ health disturbance, possibilities of prevention/treatment of a disease or a health disturbance as well as with regard to risks associated with (1) the generation of the sample required for the genetic testing and (2) the knowledge of the results of the genetic testing. All my questions have been answered and I have had the necessary consideration time. if these members have consented, and the results of the genetic analysis and examination, as well as the remaining samples (including original and processed samples; together the remaining samples ) for a period of at least 20 years. The retention of these results and of my remaining samples may be useful for advising/testing me and my family members with regard to the above specified disease, for the verification/checking of results, for requests, for quality assurance, for the tracking of latest scientific findings related to the results, to improve the diagnostics and treatment of genetic diseases and for internal and external research in the field of genetic diseases and of biological mechanisms that may lead to diseases. Incidental Findings yes no Mandatory With my signature at the end of this declaration I give my consent (1) to the genetic analysis by CENTOGENE AG, Am Strande 7, Rostock, Germany, (CENTOGENE) for the subject stated above and which is described in more detail in the preceding written explanation of genetic analysis and in the requisition form, (2) to the collection, processing and use by my physician and CENTOGENE of my personal data (that may also refer to my health) required to conduct that analysis and to transfer my personal data between physician and CENTOGENE electronically across country borders, (3) to the generation of the necessary sample as specified by my physician and above, (4) to the storage and use of the sample for as long as it is required to verify/check the results, (5) to add to my record and use for the above purposes if applicable personal data on members of my family if these members have consented, (6) to inform me or my physician or if CENTOGENE has been instructed by a laboratory acting on behalf of my physician this laboratory about the results of the genetic analysis and (7) to provide upon my separate request to me, my physician or as the case may be the instructing laboratory the raw data of the genetic analysis. I also release CENTOGENE and its employees from their secrecy obligation as a physician or healthcare professional vis-à-vis service and external data storage providers that administer and maintain systems, databases and software of CENTOGENE or provide external data storage to CENTOGENE. I am aware that I can revoke my consent in full or in part at any time with effect for the future without stating reasons and that I have the right not to know as described in the preceding written explanation. By ticking the relevant YES boxes below, I consent to the following activities: Further storage and use of personal data, results and samples CENTOGENE stores and uses my personal data stated in the requisition form and/or provided by my physician (e.g. name, birthday, address, description and symptoms of the disease), the personal data on members of my family (e.g. names and the symptoms of the disease) As the whole exome sequencing and the whole genome sequencing tests are analyzing numerous different genes, there is a possibility for the recognition of incidental findings that are not necessarily related to the reason for ordering whole exome sequencing/whole genome sequencing. These findings can provide information that was not anticipated and that are unrelated to your reported clinical features, but can be of medical value for patient care. I agree, that CENTOGENE generally reports mutations of the specified classes or types in the genes in accordance with the ACMG Recommendations for Reporting of Incidental Findings. However, I agree, that CENTOGENE may in its sole discretion also report (other) incidental findings in other cases or refrain from reporting incidental findings although this is recommended as per the said recommendations. yes no Storage and use of personal data and samples for research and other purposes as well as to facilitate and improve the diagnosis My test results and remaining samples can help to promote research and improve the diagnosis and treatment of genetic diseases. CENTOGENE, for example, may use the results and remaining samples for research purposes (e.g. to detect and develop biomarkers) as well as to facilitate and improve the diagnosis of genetic changes and diseases (also) for other patients. CENTOGENE also operates a database in which a huge number of results of genetic tests that were rendered anonymous or pseudonymous are stored. CENTOGENE may also provide access to this database to external physicians, scientists, researchers and (pharmaceutical) companies for research purposes, as well as to facilitate and improve the diagnosis of genetic changes and diseases (also) in other patients. The test results contained in the database are anonymous for the physicians, scientists, researchers and companies. Anonymized test results in CENTOGENE s database cannot be destroyed as they become unidentifiable and untraceable after their input into CENTOGENE s database. Mandatory Place, Date yes no Name of Patient/ Guardian Signature of Patient/ Guardian Page 3 Page 1 of 2 V6.1eng_November2017
4 Mandatory Part (II): Confirmation of patient consent by physician Name of patient: DOB: M M D D Y Y Y Y Patient-ID: (please provide always at least two identifiers, e.g. name of patient and date of birth) Examination target: CENTOGENE AG, Am Strande 7, Rostock, Germany (CENTOGENE), is subject to German legislation which requires a specified patient consent form to be signed by the patient for conducting genetic analyses. Under the specific circumstances of the institution the undersigned is working for, patients declare an individual consent according to local requirements in the local language. We/I hereby confirm that the following requirements are met with respect to the consent that has been declared by the patient or (as the case may be) his/her legal representative: The patient has been duly informed with regard to the specific case about the purpose, scope, type and significance of the planned genetic test(s), achievable results by the planned test, the limitations of the test, the importance of the analyzed genetic characteristics for his/her disease/health disturbance, possibilities of prevention/treatment of a disease or a health disturbance, the planned use of the sample (including processed samples) and of the test results as well as with regard to risks associated with (1) the generation of the sample required for the genetic testing and (2) the knowledge of the results of the genetic testing. The patient was informed that the test will cover all disorders indicated on the requisition form, and we/i will ensure that the test results will be interpreted to the patient in an appropriate manner, and that the patient will not receive the results without accompanying counseling. The patient was informed that she/he has the right (1) to revoke his/her consent at any time with effect for the future and (2) not to be informed about test results (right not to know), (3) to stop the testing processes that have been started at any time up to being given the results and (4) to request the destruction of all test/examination results not already known to him/her. We/I confirm that the patient is legally capable of providing this consent (respectively that the consent was given by an authorized representative), that all questions of the patient have been answered, that the patient had the necessary consideration time and that the patient has not exercised his right not to know. We/I confirm that the patient has consented to (1) to the genetic analysis by CENTOGENE for the subject stated above and which is described in more detail in the preceding written explanation of genetic analysis and in the requisition form, (2) the collection, processing and use of his/her personal (health) data by CENTOGENE required to conduct the analysis and to transfer his/her personal data between physician and CENTOGENE electronically across country borders, (3) the generation of the sample, (4) to the storage and use of the sample for as long as it is required to verify/ check the results, (5) adding to his/her record and using for the above purposes personal data on members of his/her family if these members have consented, (6) inform him/her or me or in case CENTOGENE has been instructed by a laboratory acting on my behalf this laboratory about the results of the genetic analysis and (7) to provide upon his/her separate request to him, me or as the case may be the instructing laboratory the raw data of the genetic analysis. Place, Date Name of Physician Contact Details Customer Service Tel.: +49 (0) Fax: +49 (0) Page 4 dmqc@centogene.com Physician Copy We/I confirm that the patient has released CENTOGENE and its employees from their secrecy obligations as physician or healthcare professional vis-à-vis service and external data storage providers that administer and maintain databases and software of CENTOGENE or provide external data storage to CENTOGENE. Furthermore, we/i confirm that: The patient agrees that CENTOGENE stores and uses (1) his/her personal data stated in the requisition form and/ or provided by me/us, personal data on his/her family if his/ her family members have consented the results of the genetic analysis as well as the remaining samples for a period of at least 20 years for the purposes of advising/testing his/her family members with regard to the disease specified in the consent, for the verification/checking of results, for requests, for quality assurance, for the tracking of latest scientific findings related to the results, to improve the diagnostics and treatment of genetic diseases and for internal and external research in the field of genetic diseases and of biological mechanisms that may lead to diseases and (2) his/her personal data, the results of the genetic analysis as well as the remaining samples for any later examinations of him/her. yes The patient agrees that he/she wants to be informed about incidental findings, i.e. findings that are not directly related to the actual issue. yes The patient agrees that CENTOGENE stores and uses (1) his/her remaining samples and test results that may contain data about his/her health for research purposes (e.g. to detect and develop biomarkers) as well as to facilitate and improve the diagnosis of genetic changes and diseases (also) in other patients and (2) his/her test results that may contain data about his/her health in an anonymized or pseudonymized form together with other test results in a database and provides access to the database to physicians, scientists, researchers and (pharmaceutical) companies for research and other purposes, as well as to facilitate and improve the diagnosis of genetic changes and diseases (also) for other patients. The test results contained in the database are anonymous for the physicians, scientists, researchers and companies. We/I also confirm that the patient was informed that anonymized test results in CENTOGENE s database cannot be destroyed as they become unidentifiable and untraceable after their input into CENTOGENE s database. yes no We/I confirm that we/i have the patient s signature on file for all of the issues mentioned above and that we/i are aware that the patient can request us to have his/her results eliminated if they are not already known to him/her at any time and that we/i shall convey this request to CENTOGENE. We/I confirm that we/i will retain the consent form signed by the patient for an unlimited period of time and that we will provide CENTOGENE with this form upon first request. Signature of Physician Please send the samples together with a completed request form to: no no CENTOGENE AG Am Strande Rostock Germany Page 2 of 2 V6.1eng_November2017 Mandatory
5 MANDATORY Please provide detailed clinical information Pedigree Patient name Age of manifestation Family history: Unaffected A. Consanguinity B. Affected siblings YES YES NO NO Clinical information Please tick the appropriate phenotype(s) A. NEUROLOGY 7.8 Stroke 2. Skin and integument 3. Endocrine 1. Behavioral abnormality 1.1 Autism B. METABOLISM 1. Abnormal creatine kinase 2.1 Abnormal hair 2.2 Abnormal nail 3.1 Diabetes mellitus 3.2 Hyperparathyroidism 1.2 Attention deficit disorder 2. Decreased plasma carnitine 2.3 Abnormal skin pigmentation 3.3 Hyperthyroidism 1.3 Psychiatric diseases 3. Hyperalaninemia 2.4 Hyperextensible skin 3.4 Hypoparathyroidism 2. Brain imaging 2.1 Abnormal cortical gyration 2.2 Abnormal myelination 4. Hypoglycemia 5. Increased CSF lactate 6. Increased serum pyruvate 2.5 Ichthyosis F. CARDIOVASCULAR 1. Angioedema 3.5 Hypothyroidism H. REPRODUCTION 1. Abnormal external genitalia 2.3 Agenesis of corpus callosum 7. Ketosis 2. Aortic dilatation 2. Abnormal internal genitalia 2.4 Brain atrophy 8. Lactic acidosis 3. Arrhythmia 3. Hypogonadism 2.5 Cerebellar hypoplasia 9. Organic aciduria 4. Atrial septal defect 4. Hypospadias 2.6 Heterotopia 2.7 Holoprosencephaly 2.8 Hydrocephalus C. EYE 1. Blepharospasm 2. Cataract 5. Coarctation of aorta 6. Dilated cardiomyopathy 7. Hypertension 5. Infertility I. ONCOLOGY 1. Adenomatous colonic polyposis 2.9 Leukodystrophy 3. Coloboma 8. Hypertrophic cardiomyopathy 2. Breast carcinoma 2.10 Lissencephaly 4. Glaucoma 9. Hypotension 3. Colorectal carcinoma 3. Developmental delay 5. Microphthalmos 10. Lymphedema 4. Leukemia 3.1 Delayed language dev. 6. Nystagmus 11. Malf. of heart and great vessels 5. Myelofibrosis 3.2 Delayed motor dev. 7. Ophthalmoplegia 12. Myocardial infarction 6. Neoplasm of the lung 3.3 Developmental regression 8. Optic atrophy 13. Stroke 7. Neoplasm of the skin 3.4 Intellectual disability 9. Ptosis 14. Tetralogy of Fallot 8. Paraganglioma 4. Movement abnormality 10. Retinitis pigmentosa 15. Vasculitis 9. Pheochromocytoma 4.1 Ataxia 4.2 Chorea 4.3 Dystonia 11. Retinoblastoma 12. Strabismus 13. Visual impairment 16. Ventricular septal defect G. GASTROINTESTINAL, GENITOURINARY, ENDOCRINE J. HEMATOLOGY AND IMMUNOLOGY 1. Abnormal hemoglobin 2. Abnormality of coagulation 4.4 Parkinsonism 5. Neuromuscular abnormality D. MOUTH, THROAT AND EAR 1. Abnormality of dental color 1. Gastrointestinal 1.1 Aganglionic megacolon 3. Anemia 4. Immunodeficiency 5.1 Hyperreflexia 2. Cleft lip / palate 1.2 Constipation 5. Neutropenia 5.2 Muscle hypertonia 3. Conductive hearing impair. 1.3 Diarrhea 6. Pancytopenia 5.3 Muscle hypotonia 4. External ear malformation 1.4 Gastroschisis 7. Splenomegaly 5.4 Spasticity 5. Hypodontia 1.5 Hepatic failure 8. Thrombocytopenia 6. Seizures 6.1 Febrile seizures 6.2 Focal seizures 6. Sensoneural hearing impair. E. SKIN, INTEGUMENT AND SKELETAL 1. Skeletal 1.6 Hepatomegaly 1.7 High hepatic transaminases 1.8 Obesity K. PRENATAL AND DEVELOPMENT 1. Abnormal facial shape 2. Failure to thrive 6.3 Generalized seizures 1.1 Abnormal limb morphology 1.9 Pyloric stenosis 3. Hemihypertrophy 7. Others 7.1 Craniosynostosis 7.2 Dementia 7.3 Encephalopathy 7.4 Headache 7.5 Macrocephaly 7.6 Microcephaly 7.7 Migraine 1.2 Abnormal vertebral column 1.3 Abnormality of the skeletal system 1.4 Joint hypermobility 1.5 Multiple joint contractures 1.6 Polydactyly 1.7 Scoliosis 1.8 Syndactyly 1.9 Talipes equinovarus 1.10 Vomiting 2. Genitourinary 2.1 Abnormal renal morphology 2.2 Abnormal urinary system 2.3 Hydronephrosis 2.4 Renal agenesis 2.5 Renal cyst 2.6 Renal tubular dysfunction 4. Hydrops fetalis 5. IUGR 6. Oligohydramnios 7. Overgrowth 8. Polyhydramnios 9. Premature birth 10. Short stature 11. Tall stature Page 5
6 Metabolic Diseases - Panels Panel name Brain iron accumulation syndromes panel Ceroid lipofuscinosis panel Congenital glycosylation disease panel Diabetes neonatal panel Genes ATP13A2, C19orf12, COASY, CP, DCAF17, FA2H, FTL, PANK2, PLA2G6, SCP2, WDR45 ATP13A2, CLN3, CLN5, CLN6, CLN8, CTSD, CTSF, DNAJC5, GRN, KCTD7, MFSD8, PPT1, TPP1 ALG1, ALG11, ALG12, ALG13, ALG2, ALG3, ALG6, ALG8, ALG9, ATP6V0A2, B4GALT1, COG1, COG4, COG5, COG6, COG7, COG8, DDOST, DHDDS, DOLK, DPM1, DPM2, DPM3, GMPPA, GNE, LARGE, MAN1B1, MGAT2, MOGS, MPDU1, MPI, NGLY1, PGM1, PMM2, RFT1, SLC35A1, SLC35A2, SLC35C1, SRD5A3, SSR4, STT3A, STT3B, TMEM165, TUSC3 ABCC8, FOXP3, G6PC2, GCK, GLIS3, INS, INSR, KCNJ11, NEUROG3, PDX1 GATA1, RPL11, RPL15, RPL26, RPL27, RPL31, RPL35A, RPL5, RPS10, RPS17, RPS19, RPS24, RPS26, RPS27, RPS28, RPS29, RPS7, TSR2 Deletion / duplication testing Test (genes analyzed) S D R H C V G P PANK2, ATP13A2, PLA2G S D V G P ATP13A2, GRN, CLN S D V G P LARGE 5083 S D V G ABCC8, GCK, PDX1, INS, KCNJ S D V G P Diamond-Blackfan anemia panel RPL35A, RPS17, RPL11, RPL5, RPS26, RPS S D G P Familial hypercholesterolemia panel APOB, GHR, LDLR, PCSK9 LDLR, GHR 5214 S D V G P Fatty acid oxidation disorder panel ACAD9, ACADM, ACADS, ACADVL, CPT1A, CPT2, ETFA, ETFB, ETFDH, GLUD1, HADH, HADHA, HADHB, HMGCL, HSD17B10, PPARG, SLC22A5, SLC25A20, TAZ PPARG, SLC22A5, ACADVL 5268 S D V G P Glycogen storage disease panel (basic) G6PC, SLC37A4, AGL, GBE S V G P Glycogen storage disease panel (advanced) Hyperinsulinemic hypoglycemia panel Leigh syndrome and mitochondrial encephalopathy panel Lipodystrophy panel GYS1, GYS2, G6PC, SLC37A4, GAA, AGL, GBE1, PYGM, PYGL, PFKM, PHKA2, PGAM2, LDHA, ALDOA, ENO3, PHKB, PHKA1, PGM1, GYG1, PRKAG2, PHKG2 ABCC8, GCK, GLUD1, HADH, INSR, KCNJ11, SLC16A1 ACAD9, COQ8A, AIFM1, APTX, ATPAF2, BCS1L, TWNK, NDUFAF6, COQ2, COQ9, COX10, COX15, COX6B1, DARS2, DGUOK, DLAT, DLD, DNM1L, ETFDH, ETHE1, FASTKD2, FH, FOXRED1, GFER, GFM1, LRPPRC, MPV17, NDUFA1, NDUFA10, NDUFA11, NDUFA2, NDUFA13, NDUFAF1, NDUFAF2, NDUFAF4, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFS8, NDUFV1, NDUFV2, NUBPL, NDUFA12, NDUFA9, NDUFAF5, SDHA, PC, PDHA1, PDHB, PDHX, PDP1, PDSS1, PDSS2, RARS2, SCO1, SCO2, SDHAF1, SUCLA2, SUCLG1, SURF1, TACO1, TK2, TMEM70, TSFM, TTC19, TUFM, TYMP AGPAT2, BSCL2, CAV1, CIDEC, LIPE, LMNA, PIK3R1, PLIN1, PPARG, PTRF ARSA, FUCA1, GALC, GBA, GLB1, GNPTAB, GUSB, HEXA, HEXB, MAN2B1, MANBA, NAGA, SMPD1 GAA 5204 S D V G P ABCC8, GCK, KCNJ S D V G P TWNK, SDHAF1, SUCLA2, COX10, APTX, SUCLG1, MPV17, DGUOK, PDHA1, SDHA, FH, TK S D V G P PPARG, LMNA 5308 S D V G Lysosomal storage disease panel HEXA, SMPD1, GALC 5101 S D V G P Methylmalonic acidemia panel (basic) MCEE, MMAA, MMAB, MMADHC, MUT 5216 S V G P Methylmalonic acidemia panel (advanced) SUCLA2, SUCLG1, MLYCD 5217 S D V G P MODY panel ABCD4, ACSF3, CD320, LMBRD1, MCEE, MLYCD, MMAA, MMAB, MMACHC, MMADHC, MTR, MTRR, MUT, SUCLA2, SUCLG1 ABCC8, BLK, CEL, GCK, HNF1A, HNF1B, HN- F4A, INS, KCNJ11, KLF11, NEUROD1, NKX2-2, PAX4, PDX1, RFX6, ZFP57 ARSB, GALNS, GLB1, GNPTAB, GNPTG, GNS, GUSB, HGSNAT, IDS, IDUA, NAGLU, SGSH ABCC8, CEL, GCK, KCNJ11, HNF4A, PDX1, HNF1A, INS, PAX4, NEUROD1, HNF1B, ZFP57, KLF S D V G P Mucopolysaccharidosis panel IDS 5069 S D V G P Non ketotic hyperglycinemia panel AMT, GCSH, GLDC GLDC, GCSH, AMT 5345 S D V P Obesity panel ALMS1, ARL6, BBIP1, BBS1, BBS10, BBS12, BBS2, BBS4, BBS5, BBS7, BBS9, CEP290, CUL4B, DYRK1B, GNAS, IFT27, LEP, LEPR, LZT- FL1, MAGEL2, MC4R, MKKS, MKS1, NR0B2, NTRK2, PCSK1, PHF6, POMC, SDCCAG8, SIM1, TRIM32, TTC8, UCP3, VPS13B, WDPCP GNAS, LEP, LEPR, MC4R, POMC, SIM1, VPS13B 5301 S D Refsum disease panel PEX1, PEX2, PEX26, PEX7, PHYH 5094 S V G P ABCA3, CSF2RA, CSF2RB, SFTPA1, SFTPB, Surfactant metabolism dysfunction panel CSF2RA 5211 SFTPC, SFTPD S D V G P Urea cycle disorder panel ARG1, ASL, ASS1, CPS1, NAGS, OTC OTC 5072 S D V G P Zellweger syndrome panel 5049 S V G P PEX1, PEX2, PEX3, PEX5, PEX6, PEX10, PEX12, PEX13, PEX14, PEX16, PEX19, PEX26 Page 6
7 Metabolic Diseases - Large Extended Screening Panels Panel name CentoICU platinum Genes AARS, AARS2, AASS, ABAT, ABCA12, ABCA3, ABCB11, ABCC8, ABCD1, ABCD3, ABCD4, ACAD8, ACAD9, ACADM, ACADS, ACADSB, ACADVL, ACAT1, ACO2, ACOX1, ACSF3, ACTA1, ADA, ADAMTS13, ADAR, ADK, ADNP, ADSL, AGK, AGL, AGRN, AGXT, AHCY, AICDA, AIFM1, AIMP1, AKAP9, AKR1D1, ALAD, ALAS2, ALDH18A1, ALDH3A2, ALDH4A1, ALDH5A1, ALDH6A1, ALDH7A1, ALDOA, ALDOB, ALG14, ALG2, ALG3, ALG6, ALMS1, ALOX12B, ALOXE3, ALPL, ALS2, AMACR, AMT, ANK1, ANKRD26, ANKS6, ANTXR1, AP2S1, AP4B1, AP4E1, AP4M1, AP4S1, APOB, ARG1, ARL6, ARSA, ARSB, ARX, ASL, ASNS, ASPA, ASPM, ASS1, ATP1A3, ATP6V1B1, ATP7A, ATP7B, ATP8B1, ATPAF2, ATR, ATRX, AUH, BCAP31, BCKDHA, BCKDHB, BCKDK, BCS1L, BDNF, BICD2, BIN1, BLNK, BOLA3, BRAF, BRAT1, BRCA2, BSND, BTD, BTK, C10orf2, C12orf65, C21orf59, CA12, CACNA1C, CACNB2, CALM1, CAMTA1, CASK, CASR, CAST, CAV3, CBS, CCDC103, CCDC114, CCDC78, CD19, CD247, CD320, CD3D, CD3E, CD3G, CD40, CD40LG, CD59, CD79A, CD79B, CD81, CD96, CDAN1, CDK5RAP2, CDKL5, CDKN1C, CENPJ, CEP152, CEP290, CERS3, CFH, CFHR3, CFL2, CFTR, CHAT, CHD7, CHKB, CHM, CHRNA1, CHRNB1, CHRND, CHRNE, CIDEC, CLCNKA, CLCNKB, CLPB, CNTN1, COA5, COL11A1, COL17A1, COL1A1, COL1A2, COL2A1, COL3A1, COL5A2, COL6A1, COL6A2, COL6A3, COL7A1, COLQ, COMP, COQ2, COQ9, CORO1A, COX10, COX15, COX20, COX6B1, CPS1, CPT1A, CPT2, CR2, CRTAP, CTNS, CTPS1, CTSA, CTSD, CUL4B, CXCR4, CYP11B1, CYP11B2, CYP17A1, CYP4F22, CYP7B1, D2HGDH, DBT, DCLRE1C, DDC, DDOST, DDR2, DECR1, DEPDC5, DES, DGUOK, DHCR24, DHCR7, DIAPH1, DLAT, DLD, DMD, DNA2, DNAH11, DNAH5, DNAI1, DNAI2, DNAJC19, DNM2, DOCK7, DOCK8, DOK7, DOLK, DPAGT1, DPM2, DPYD, DRC1, DSP, DST, DUOX2, DUOXA2, DYSF, EDN3, EEF1A2, EGR2, EIF2AK3, EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5, ELAC2, ELANE, ENPP1, EPB42, EPCAM, ETFA, ETFB, ETFDH, ETHE1, EVC, EVC2, EXOSC3, EYA1, EYA4, F10, F11, F13A1, F2, F5, F7, F8, F9, FADD, FAH, FANCA, FANCB, FANCC, FANCD2, FANCL, FARS2, FASTKD2, FBN1, FBP1, FBXL4, FGA, FGB, FGFR2, FGFR3, FGG, FH, FIG4, FKBP14, FKRP, FKTN, FOXC1, FOXG1, FOXP3, FOXRED1, FRAS1, FUCA1, G6PC2, G6PD, GAA, GALC, GALE, GALK1, GALNS, GALT, GAMT, GAN, GARS, GATA1, GATM, GBA, GBE1, GCDH, GCH1, GCK, GCSH, GDAP1, GFAP, GFM1, GFPT1, GJA1, GJB2, GJB4, GK, GLA, GLB1, GLDC, GLIS3, GLRA1, GLRB, GLUD1, GLYCTK, GMPPB, GNAS, GNE, GNMT, GNPAT, GNPTAB, GP1BA, GP1BB, GP9, GPC3, GPHN, GPSM2, GSS, GUSB, GYS2, HADH, HADHA, HADHB, HAMP, HAX1, HBA1, HBA2, HBB, HESX1, HEXA, HEXB, HGD, HGF, HIBCH, HLCS, HMGCL, HMGCS2, HNF1A, HNF1B, HNF4A, HPD, HPGD, HRAS, HSD17B10, HSD17B4, HSD3B2, HSD3B7, HSPA9, HSPD1, HSPG2, ICOS, IDUA, IER3IP1, IFIH1, IFT172, IGF1, IGF1R, IGHMBP2, IGLL1, IKBKB, IL12RB1, IL2RA, IL2RG, IL7R, INS, INSR, INVS, IRF8, ISPD, ITGA2B, ITGA6, ITGA7, ITGB3, ITGB4, IVD, JAG1, JAGN1, JAK3, JAM3, KAT6A, KAT6B, KBT- BD13, KCNE1, KCNH1, KCNH2, KCNJ10, KCNJ11, KCNQ1, KCNQ2, KCNQ3, KCNT1, KCTD7, KIF1B, KLF1, KLHL40, KLHL41, KRAS, KRT5, LAMA2, LAMA3, LAMB3, LAMC2, LAMP2, LAMTOR2, LARS2, LAS1L, LCT, LHX3, LHX4, LIAS, LIG4, LIPA, LIPN, LIPT1, LMBRD1, LMNA, LPIN1, LRBA, LRPPRC, LRRC8A, MAGEL2, MAGT1, MALT1, MAN2B1, MANBA, MAP2K1, MAP2K2, MASTL, MAT1A, MCCC1, MCCC2, MCEE, MCM4, MCPH1, MECP2, MED12, MEF2C, MEGF10, MFN2, MFSD8, MITF, MKKS, MLC1, MLYCD, MMAA, MMAB, MMACHC, MMADHC, MOCS1, MOCS2, MPC1, MPI, MPL, MPV17, MPZ, MRPL3, MRPL44, MSMO1, MTHFR, MTM1, MTMR14, MTO1, MTR, MTRR, MUSK, MUT, MVK, MYCN, MYH9, NAA10, NAGA, NAGS, NALCN, NARS2, NBAS, NDUFA1, NDUFA10, NDUFA11, NDUFA2, NDUFA9, NDUFAF1, NDUFAF2, NDUFAF3, NDUFAF4, NDUFAF5, NDUFAF6, NDUFB3, NDUFB9, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFV1, NDUFV2, NEB, NEFL, NEU1, NEUROG3, NEXN, NFKB2, NFU1, NGF, NHEJ1, NIPAL4, NIPBL, NKX2-1, NKX2-5, NLRC4, NLRP3, NOTCH2, NPC1, NPC2, NPHP1, NPHP3, NR0B1, NR3C2, NRAS, NSD1, NSDHL, NUBPL, OAT, OCLN, OCRL, OPA3, OPHN1, OPLAH, ORC1, ORC4, OTC, OXCT1, PAFAH1B1, PAH, PAX2, PAX3, PAX6, PAX8, PC, PCBD1, PCCA, PCCB, PCDH19, PCNT, PDCD10, PDE10A, PDHA1, PDHB, PDHX, PDP1, PDSS2, PDX1, PEPD, PEX1, PEX10, PEX13, PEX19, PEX7, PGAP1, PHGDH, PHOX2B, PIGA, PIGN, PIGT, PIGV, PIK3CD, PKD2, PKHD1, PKLR, PLCB4, PLEC, PLOD1, PLP1, PMM2, PMP22, PNKP, PNP, PNPLA1, PNPO, PNPT1, POGZ, POLG, POLG2, POMGNT1, POMGNT2, POMK, POMT1, POMT2, POU1F1, PPT1, PRDM16, PRKAG2, PRKDC, PROC, PRODH, PROP1, PROS1, PRPS1, PRRT2, PSAP, PSAT1, PSPH, PTPN11, PTPRC, PTRF, PTRH2, PTS, PURA, QDPR, RAB18, RAB3GAP1, RAB3GAP2, RAC2, RAF1, RAG1, RAG2, RANBP2, RAPSN, RARS2, RB1, RBBP8, RBM8A, RET, RFT1, RFX5, RFX6, RIT1, RMND1, RMRP, RNASEH2C, RNASET2, RNU4ATAC, RORC, RPS19, RRM2B, RYR1, SALL1, SATB2, SBDS, SCN1A, SCN2A, SCN4A, SCN5A, SCN9A, SCO1, SCO2, SDHA, SDHAF1, SEPN1, SERAC1, SERPINC1, SERPING1, SFT- PB, SFTPC, SFTPD, SHOC2, SIL1, SIX3, SIX5, SKI, SLC12A6, SLC16A1, SLC16A2, SLC17A5, SLC19A2, SLC19A3, SLC22A5, SLC25A1, SLC25A12, SLC25A13, SLC25A15, SLC25A19, SLC25A20, SLC25A22, SLC25A3, SLC26A2, SLC26A3, SLC2A1, SLC30A2, SLC33A1, SLC37A4, SLC3A1, SLC46A1, SLC4A1, SLC52A1, SLC52A3, SLC5A1, SLC5A5, SLC6A1, SLC6A3, SLC6A5, SLC7A7, SLC7A9, SLCO1B1, SLCO1B3, SMPD1, SNAI2, SNX10, SOS1, SOX10, SOX2, SOX9, SPAST, SPEG, SPINK5, SPINT2, SPR, SPRED1, SPTA1, SPTAN1, SPTB, SRD5A3, ST3GAL3, ST3GAL5, STAR, STAT1, STAT3, STIL, STIM1, STS, STT3B, STXBP1, SUCLA2, SUCLG1, SUMF1, SUOX, SYNE1, TACO1, TAT, TAZ, TBC1D24, TBCE, TBX19, TBX5, TCAP, TCN2, TFR2, TG, TGM1, TH, THRA, TJP2, TMCO1, TMEM165, TMEM173, TMEM5, TMEM70, TNFRSF13B, TNFRSF13C, TNFSF4, TNNT1, TP63, TPM2, TPM3, TPO, TPP1, TRIP11, TRMU, TRPV4, TSC1, TSC2, TSFM, TSHB, TSHR, TSPYL1, TTC7A, TTN, TUBA8, TUBB2A, UBA1, UGT1A1, UMPS, UNG, UPB1, UQCRC2, UROD, UROS, WAS, WDPCP, WDR62, WDR73, WFS1, WNK1, WT1, ZAP70, ZEB2, ZFP57, ZNF423 Test 5288 L P L P* Page 7
8 Panel name CentoICU platinum plus Genes AARS, AARS2, AASS, ABAT, ABCA12, ABCA3, ABCB11, ABCC8, ABCD1, ABCD3, ABCD4, ACAD8, ACAD9, ACADM, ACADS, ACADSB, ACADVL, ACAT1, ACO2, ACOX1, ACSF3, ACTA1, ADA, ADAMTS13, ADAR, ADK, ADNP, ADSL, AGK, AGL, AGRN, AGXT, AHCY, AICDA, AIFM1, AIMP1, AKAP9, AKR1D1, ALAD, ALAS2, ALDH18A1, ALDH3A2, ALDH4A1, ALDH5A1, ALDH6A1, ALDH7A1, ALDOA, ALDOB, ALG14, ALG2, ALG3, ALG6, ALMS1, ALOX12B, ALOXE3, ALPL, ALS2, AMACR, AMT, ANK1, ANKRD26, ANKS6, ANTXR1, AP2S1, AP4B1, AP4E1, AP4M1, AP4S1, APOB, ARG1, ARL6, ARSA, ARSB, ARX, ASL, ASNS, ASPA, ASPM, ASS1, ATP1A3, ATP6V1B1, ATP7A, ATP7B, ATP8B1, ATPAF2, ATR, ATRX, AUH, BCAP31, BCKDHA, BCKDHB, BCKDK, BCS1L, BDNF, BICD2, BIN1, BLNK, BOLA3, BRAF, BRAT1, BRCA2, BSND, BTD, BTK, C10orf2, C12orf65, C21orf59, CA12, CACNA1C, CACNB2, CALM1, CAMTA1, CASK, CASR, CAST, CAV3, CBS, CCDC103, CCDC114, CCDC78, CD19, CD247, CD320, CD3D, CD3E, CD3G, CD40, CD40LG, CD59, CD79A, CD79B, CD81, CD96, CDAN1, CDK5RAP2, CDKL5, CDKN1C, CENPJ, CEP152, CEP290, CERS3, CFH, CFHR3, CFL2, CFTR, CHAT, CHD7, CHKB, CHM, CHRNA1, CHRNB1, CHRND, CHRNE, CIDEC, CLCNKA, CLCNKB, CLPB, CNTN1, COA5, COL11A1, COL17A1, COL1A1, COL1A2, COL2A1, COL3A1, COL5A2, COL6A1, COL6A2, COL6A3, COL7A1, COLQ, COMP, COQ2, COQ9, CORO1A, COX10, COX15, COX20, COX6B1, CPS1, CPT1A, CPT2, CR2, CRTAP, CTNS, CTPS1, CTSA, CTSD, CUL4B, CXCR4, CYP11B1, CYP11B2, CYP17A1, CYP4F22, CYP7B1, D2HGDH, DBT, DCLRE1C, DDC, DDOST, DDR2, DECR1, DEPDC5, DES, DGUOK, DHCR24, DHCR7, DIAPH1, DLAT, DLD, DMD, DNA2, DNAH11, DNAH5, DNAI1, DNAI2, DNAJC19, DNM2, DOCK7, DOCK8, DOK7, DOLK, DPAGT1, DPM2, DPYD, DRC1, DSP, DST, DUOX2, DUOXA2, DYSF, EDN3, EEF1A2, EGR2, EIF2AK3, EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5, ELAC2, ELANE, ENPP1, EPB42, EPCAM, ETFA, ETFB, ETFDH, ETHE1, EVC, EVC2, EXOSC3, EYA1, EYA4, F10, F11, F13A1, F2, F5, F7, F8, F9, FADD, FAH, FANCA, FANCB, FANCC, FANCD2, FANCL, FARS2, FASTKD2, FBN1, FBP1, FBXL4, FGA, FGB, FGFR2, FGFR3, FGG, FH, FIG4, FKBP14, FKRP, FKTN, FOXC1, FOXG1, FOXP3, FOXRED1, FRAS1, FUCA1, G6PC2, G6PD, GAA, GALC, GALE, GALK1, GALNS, GALT, GAMT, GAN, GARS, GATA1, GATM, GBA, GBE1, GCDH, GCH1, GCK, GCSH, GDAP1, GFAP, GFM1, GFPT1, GJA1, GJB2, GJB4, GK, GLA, GLB1, GLDC, GLIS3, GLRA1, GLRB, GLUD1, GLYCTK, GMPPB, GNAS, GNE, GNMT, GNPAT, GNPTAB, GP1BA, GP1BB, GP9, GPC3, GPHN, GPSM2, GSS, GUSB, GYS2, HADH, HADHA, HADHB, HAMP, HAX1, HBA1, HBA2, HBB, HESX1, HEXA, HEXB, HGD, HGF, HIBCH, HLCS, HMGCL, HMGCS2, HNF1A, HNF1B, HNF4A, HPD, HPGD, HRAS, HSD17B10, HSD17B4, HSD3B2, HSD3B7, HSPA9, HSPD1, HSPG2, ICOS, IDUA, IER3IP1, IFIH1, IFT172, IGF1, IGF1R, IGHMBP2, IGLL1, IKBKB, IL12RB1, IL2RA, IL2RG, IL7R, INS, INSR, INVS, IRF8, ISPD, ITGA2B, ITGA6, ITGA7, ITGB3, ITGB4, IVD, JAG1, JAGN1, JAK3, JAM3, KAT6A, KAT6B, KBT- BD13, KCNE1, KCNH1, KCNH2, KCNJ10, KCNJ11, KCNQ1, KCNQ2, KCNQ3, KCNT1, KCTD7, KIF1B, KLF1, KLHL40, KLHL41, KRAS, KRT5, LAMA2, LAMA3, LAMB3, LAMC2, LAMP2, LAMTOR2, LARS2, LAS1L, LCT, LHX3, LHX4, LIAS, LIG4, LIPA, LIPN, LIPT1, LMBRD1, LMNA, LPIN1, LRBA, LRPPRC, LRRC8A, MAGEL2, MAGT1, MALT1, MAN2B1, MANBA, MAP2K1, MAP2K2, MASTL, MAT1A, MCCC1, MCCC2, MCEE, MCM4, MCPH1, MECP2, MED12, MEF2C, MEGF10, MFN2, MFSD8, MITF, MKKS, MLC1, MLYCD, MMAA, MMAB, MMACHC, MMADHC, MOCS1, MOCS2, MPC1, MPI, MPL, MPV17, MPZ, MRPL3, MRPL44, MSMO1, MTHFR, MTM1, MTMR14, MTO1, MTR, MTRR, MUSK, MUT, MVK, MYCN, MYH9, NAA10, NAGA, NAGS, NALCN, NARS2, NBAS, NDUFA1, NDUFA10, NDUFA11, NDUFA2, NDUFA9, NDUFAF1, NDUFAF2, NDUFAF3, NDUFAF4, NDUFAF5, NDUFAF6, NDUFB3, NDUFB9, NDUFS1, NDUFS2, NDUFS3, NDUFS4, NDUFS6, NDUFS7, NDUFV1, NDUFV2, NEB, NEFL, NEU1, NEUROG3, NEXN, NFKB2, NFU1, NGF, NHEJ1, NIPAL4, NIPBL, NKX2-1, NKX2-5, NLRC4, NLRP3, NOTCH2, NPC1, NPC2, NPHP1, NPHP3, NR0B1, NR3C2, NRAS, NSD1, NSDHL, NUBPL, OAT, OCLN, OCRL, OPA3, OPHN1, OPLAH, ORC1, ORC4, OTC, OXCT1, PAFAH1B1, PAH, PAX2, PAX3, PAX6, PAX8, PC, PCBD1, PCCA, PCCB, PCDH19, PCNT, PDCD10, PDE10A, PDHA1, PDHB, PDHX, PDP1, PDSS2, PDX1, PEPD, PEX1, PEX10, PEX13, PEX19, PEX7, PGAP1, PHGDH, PHOX2B, PIGA, PIGN, PIGT, PIGV, PIK3CD, PKD2, PKHD1, PKLR, PLCB4, PLEC, PLOD1, PLP1, PMM2, PMP22, PNKP, PNP, PNPLA1, PNPO, PNPT1, POGZ, POLG, POLG2, POMGNT1, POMGNT2, POMK, POMT1, POMT2, POU1F1, PPT1, PRDM16, PRKAG2, PRKDC, PROC, PRODH, PROP1, PROS1, PRPS1, PRRT2, PSAP, PSAT1, PSPH, PTPN11, PTPRC, PTRF, PTRH2, PTS, PURA, QDPR, RAB18, RAB3GAP1, RAB3GAP2, RAC2, RAF1, RAG1, RAG2, RANBP2, RAPSN, RARS2, RB1, RBBP8, RBM8A, RET, RFT1, RFX5, RFX6, RIT1, RMND1, RMRP, RNASEH2C, RNASET2, RNU4ATAC, RORC, RPS19, RRM2B, RYR1, SALL1, SATB2, SBDS, SCN1A, SCN2A, SCN4A, SCN5A, SCN9A, SCO1, SCO2, SDHA, SDHAF1, SEPN1, SERAC1, SERPINC1, SERPING1, SFT- PB, SFTPC, SFTPD, SHOC2, SIL1, SIX3, SIX5, SKI, SLC12A6, SLC16A1, SLC16A2, SLC17A5, SLC19A2, SLC19A3, SLC22A5, SLC25A1, SLC25A12, SLC25A13, SLC25A15, SLC25A19, SLC25A20, SLC25A22, SLC25A3, SLC26A2, SLC26A3, SLC2A1, SLC30A2, SLC33A1, SLC37A4, SLC3A1, SLC46A1, SLC4A1, SLC52A1, SLC52A3, SLC5A1, SLC5A5, SLC6A1, SLC6A3, SLC6A5, SLC7A7, SLC7A9, SLCO1B1, SLCO1B3, SMPD1, SNAI2, SNX10, SOS1, SOX10, SOX2, SOX9, SPAST, SPEG, SPINK5, SPINT2, SPR, SPRED1, SPTA1, SPTAN1, SPTB, SRD5A3, ST3GAL3, ST3GAL5, STAR, STAT1, STAT3, STIL, STIM1, STS, STT3B, STXBP1, SUCLA2, SUCLG1, SUMF1, SUOX, SYNE1, TACO1, TAT, TAZ, TBC1D24, TBCE, TBX19, TBX5, TCAP, TCN2, TFR2, TG, TGM1, TH, THRA, TJP2, TMCO1, TMEM165, TMEM173, TMEM5, TMEM70, TNFRSF13B, TNFRSF13C, TNFSF4, TNNT1, TP63, TPM2, TPM3, TPO, TPP1, TRIP11, TRMU, TRPV4, TSC1, TSC2, TSFM, TSHB, TSHR, TSPYL1, TTC7A, TTN, TUBA8, TUBB2A, UBA1, UGT1A1, UMPS, UNG, UPB1, UQCRC2, UROD, UROS, WAS, WDPCP, WDR62, WDR73, WFS1, WNK1, WT1, ZAP70, ZEB2, ZFP57, ZNF423 Test 5289 L P L P* Metabolic Diseases Test Disease Gene OMIM Gene S D R H C P 2-aminoadipic 2-oxoadipic aciduria DHTKD S 2-methylbutyrylglycinuria ACADSB S 3-beta-hydroxysteroid dehydrogenase deficiency type 2 HSD3B S D P 3-hydroxy-3-methylglutaryl-CoA lyase deficiency HMGCL S D 3-hydroxy-3-methylglutaryl-CoA synthase 2 deficiency HMGCS S D 3-hydroxyisobutryl-CoA hydrolase deficiency HIBCH S 3-methylglutaconic aciduria type 1 AUH S D P 3-methylglutaconic aciduria type 3 OPA S D H P 3-methylglutaconic aciduria type 5 DNAJC S 3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome SERAC S D 5-oxoprolinase deficiency OPLAH S 6q24-related transient neonatal diabetes mellitus type 1 UPD chr D 17-hydroxylation activity deficiency CYP17A S D P Abetalipoproteinemia MTTP S Acetycholinesterase deficiency ACHE S Acetyl-CoA carboxylase deficiency ACACA S Acyl-CoA medium-chain dehydrogenase deficiency ACADM S D P Acyl-CoA multiple dehydrogenase deficiency ETFA S D P Acyl-CoA multiple dehydrogenase deficiency ETFB S D P Page 8
9 Test Disease Gene OMIM Gene S D R H C P Acyl-CoA short-chain dehydrogenase deficiency ACADS S D H P Acyl-CoA very long-chain dehydrogenase deficiency ACADVL S D P Adenine phosphoribosyltransferase deficiency APRT S Adenylosuccinase deficiency ADSL S Adrenal hyperplasia due to 21-hydroxylase deficiency CYP21A S D P Adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency POR S D P Adrenal hyperplasia due to steroid 11-beta-hydroxylase deficiency CYP11B S D P Adrenal hypoplasia NR0B S D P Alkaptonuria HGD S D H P Alpha-2-macroglobulin deficiency A2M S Alpha-ketoglutarate dehydrogenase deficiency OGDH S Alpha-methylacyl CoA racemase deficiency AMACR S D P Aminoacylase deficiency ACY S AMP deaminase deficiency, erythrocytic AMPD S Amyloidosis, familial visceral APOA S D Andersen disease GBE S D P Anemia dyserythropoietic type 1A CDAN S D P Anemia dyserythropoietic type 2 SEC23B S D P Antitrypsin-alpha-1 deficiency SERPINA S D H P Aplastic anemia PRF S D P Aplastic anemia TERC S D P Aplastic anemia, SBDS related SBDS S D P Apolipoprotein C-II deficiency APOC S D P Apparent mineralocorticoid excess HSD11B S D P Arginase deficiency ARG S Arginine-glycine amidinotransferase deficiency GATM S D P Argininosuccinic aciduria ASL S D H P Aromatic L-amino acid decarboxylase deficiency DDC S Asparaginesynthetase deficiency ASNS S Aspartylglucosaminuria AGA S Beta-Galactosamide alpha-2,6-sialyltransferase 2 deficiency ST6GAL S P Beta-ureidopropionase deficiency UPB S D Bile acid malabsorption, primary SLC10A S Bile acid synthesis defect type 2, congenital AKR1D S Bile acid synthesis defect type 3, congenital CYP7B S D P Bile acid synthesis defect type 4, congenital AMACR S D P Biotinidase deficiency BTD S D H P Bloom syndrome BLM S D P Branched-chain aminotransferase 1 deficiency BCAT S Branched-chain aminotransferase 2 deficiency BCAT S Branched-chain ketoacid dehydrogenase kinase deficiency BCKDK S Bronchiectasis with or without elevated sweat chloride type 2 SCNN1A S D P Butyrylcholinesterase deficiency BCHE S D Carbamoylphosphate synthetase I deficiency CPS S D P Carnitine deficiency SLC22A S D P Carnitine palmitoyltransferase 1A deficiency CPT1A S D P Carnitine palmitoyltransferase 1B deficiency CPT1B S Carnitine palmitoyltransferase 2 deficiency, infantile CPT S D P Carnitine palmitoyltransferase 2 deficiency, lethal neonatal CPT S D P Carnitine-acylcarnitine translocase deficiency SLC25A S D P Catechol-o-methyltransferase deficiency COMT S Ceroid lipofuscinosis neuronal type 1 PPT S D P Ceroid lipofuscinosis neuronal type 2 TPP S D P Ceroid lipofuscinosis neuronal type 3 CLN S D P Ceroid lipofuscinosis neuronal type 4 DNAJC S Ceroid lipofuscinosis neuronal type 5 CLN S D P Ceroid lipofuscinosis neuronal type 6 CLN S D P Ceroid lipofuscinosis neuronal type 7 MFSD S D P* Ceroid lipofuscinosis neuronal type 8 CLN S D P Ceroid lipofuscinosis neuronal type 10 CTSD S D P Ceroid lipofuscinosis neuronal type 11 GRN S D P* Chanarin-Dorfman syndrome ABHD S D P Chloramphenicol resistance, MT-RNR2 related MT-RNR S Cholestasis benign recurrent intrahepatic type 2 ABCB S D P Cholestasis intrahepatic, of pregnancy, type 3 ABCB S D P Page 9
10 Test Disease Gene OMIM Gene S D R H C P Cholestasis progressive intrahepatic type 1 ATP8B S D P Cholestasis progressive intrahepatic type 2 ABCB S D P Cholestasis progressive intrahepatic type 3 ABCB S D P Cholestasis, benign recurrent intrahepatic ATP8B S D P Cholestasis, intrahepatic, of pregnancy, type 1 ATP8B S D P Cholesteryl ester storage disease LIPA S D P Chylomicron retention disease SAR1B S Citrin deficiency SLC25A S D P Citrullinemia ASS S D P CoA-2 4-dienoyl reductase 1 deficiency DECR S CoA-3-hydroxyacyl dehydrogenase deficiency HADH S CoA-3-methylcrontonyl carboxylase 1 deficiency MCCC S CoA-3-methylcrontonyl carboxylase 2 deficiency MCCC S Colchicine resistance ABCB S Combined D-2- and L-2-hydroxyglutaric aciduria SLC25A S D Combined malonic and methylmalonic aciduria ACSF S Combined oxidative phosphorylation deficiency type 1 GFM S Combined oxidative phosphorylation deficiency type 2 MRPS S Combined oxidative phosphorylation deficiency type 3 TSFM S Combined oxidative phosphorylation deficiency type 4 TUFM S Combined oxidative phosphorylation deficiency type 5 MRPS S Combined oxidative phosphorylation deficiency type 6 AIFM S D P Combined oxidative phosphorylation deficiency type 7 C12ORF S Combined oxidative phosphorylation deficiency type 8 AARS S Combined oxidative phosphorylation deficiency type 9 MRPL S Combined oxidative phosphorylation deficiency type 10 MTO S D P Combined oxidative phosphorylation deficiency type 11 RMND S Combined oxidative phosphorylation deficiency type 12 EARS S D Combined oxidative phosphorylation deficiency type 13 PNPT S Combined oxidative phosphorylation deficiency type 14 FARS S Combined oxidative phosphorylation deficiency type 15 MTFMT S D Combined oxidative phosphorylation deficiency type 16 MRPL S Combined oxidative phosphorylation deficiency type 17 ELAC S Combined oxidative phosphorylation deficiency type 18 SFXN S Combined oxidative phosphorylation deficiency type 19 LYRM S Combined oxidative phosphorylation deficiency type 20 VARS S Combined oxidative phosphorylation deficiency type 21 TARS S Combined oxidative phosphorylation deficiency type 22 ATP5A S Combined oxidative phosphorylation deficiency type 23 GTPBP S Combined oxidative phosphorylation deficiency type 24 NARS S D Combined oxidative phosphorylation deficiency type 25 MARS S Combined oxidative phosphorylation deficiency type 26 TRMT S Congenital disorder of glycosylation, type Ip ALG S Congenital disorder of glycosylation, type Iq SRD5A S Congenital disorder of glycosylation, type Iw STT3A S Coproporphyria CPOX S D Coumarin resistance VKORC S Coumarin/Warfarin resistance due to CYP2C9 variants CYP2C S D Creatine deficiency syndrome X-linked SLC6A S D P CYP2C19 related poor drug metabolism CYP2C S D P Cystathioninuria CTH S Cystic fibrosis CFTR S D P Cystic fibrosis, SLC6A14 related SLC6A S D Cystinosis, nephropathic CTNS S D P Cytochrome P450 deficiency CYP1A S D D-2-hydroxyglutaric aciduria type 1 D2HGDH S D P D-2-hydroxyglutaric aciduria type 2 IDH S D P D-bifunctional protein deficiency HSD17B S D P D-glyceric aciduria GLYCTK S Diabetes insipidus, nephrogenic, X-linked AVPR S D P Diabetes insipidus, neurohypophyseal AVP S D Diabetes mellitus type 1 INS S D P Diabetes mellitus, insulin-dependent type 20 HNF1A S D P* Diabetes mellitus, insulin-resistant with acanthosis nigricans INSR S D P* Diabetes mellitus, neonatal GLIS S P Page 10
11 Test Disease Gene OMIM Gene S D R H C P Diabetes mellitus, noninsulin-dependent ABCC S D P Diabetes mellitus, noninsulin-dependent AKT S Diabetes mellitus, noninsulin-dependent KCNJ S D P Diabetes mellitus, permanent neonatal ABCC S D P Diabetes mellitus, transient neonatal type 2 ABCC S D P Diabetes, IGF2 related IGF S D P Diarrhea type 1, secretory chloride, congenital SLC26A S D P Diarrhea type 4, malabsorptive, congenital NEUROG S D P Dihydropyrimidine dehydrogenase deficiency DPYD S D Dihydropyrimidinuria DPYS S Dimethylglycine dehydrogenase deficiency DMGDH S Dyggve-Melchior-Clausen disease DYM S Efavirenz, poor metabolism of CYP2B S D Enterokinase deficiency TMPRSS S Erythrocyte lactate transporter defect SLC16A S D P* Fabry disease GLA S D P Factor II deficiency F S H Factor V deficiency F S H P Factor XIIIB deficiency F13B S Fanconi anemia type A FANCA S D P Fanconi anemia type B FANCB S D P Fanconi anemia type C FANCC S Fanconi anemia type D1 BRCA S D Fanconi anemia type D2 FANCD S D P Fanconi anemia type E FANCE S Fanconi anemia type F FANCF S P Fanconi anemia type G FANCG S D Fanconi anemia type I FANCI S Fanconi anemia type J BRIP S D P Fanconi anemia type L FANCL S Fanconi anemia type M FANCM S Fanconi anemia type N PALB S D P Fanconi anemia type P SLX S P Fanconi anemia, XRCCR2 related XRCC S D P* Fanconi-Bickel syndrome SLC2A S D P Farber disease ASAH S D P Favism, susceptibility to G6PD S D P* Fish eye disease LCAT S D P Folate malabsorption, hereditary SLC46A S Fructose-1,6-bisphosphatase deficiency FBP S D P Fructose intolerance ALDOB S D P Fructose uptake deficiency, SLC2A5 related SLC2A S Fructosuria essential KHK S Fucosidosis FUCA S D P Fumarase deficiency FH S D P GABA-transaminase deficiency ABAT S Galactokinase deficiency GALK S D P Galactose epimerase deficiency GALE S D P Galactosemia GALT S D P Galactosialidosis CTSA S D P Gallbladder disease type 1 ABCB S D P Gaucher disease type 1 GBA S D P Gaucher disease type 2 GBA S D H P Gaucher disease type 3C GBA S D H P Gaucher disease type 3 GBA S D H P Gaucher disease, atypical PSAP S D P Gaucher disease, perinatal lethal GBA S D H P Glucocorticoid deficiency type 1 MC2R S Glucocorticoid deficiency type 2 MRAP S Glucose/Galactose malabsorption SLC5A S D P Glutamate formiminotransferase deficiency FTCD S Glutamine deficiency, congenital GLUL S Glutaric acidemia type 1 GCDH S D P Glutaric acidemia type 2C ETFDH S D P Glutaric aciduria type 3 SUGCT S Page 11
COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS
COMPREHENSIVE DIAGNOSIS FOR MITOCHONDRIAL DISORDERS MITOCHONDRIAL DISORDERS NGS PANELS MITOCHONDRIAL DISORDERS NGS PANELS Name Test code Gene Name Mitome200-Nuclear 2086 (164 nuclear genes) AARS2, ACACA,
More informationINVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS
INVITAE METABOLIC DISORDERS AND NEWBORN SCREENING GENE PANEL TESTS A broad menu covering the vast majority of inherited metabolic disorders that are routinely tested as part of state newborn screening
More informationTargeted Genes and Methodology Details for Epilepsy/Seizure Genetic Panels
Targeted s and Methodology Details for Epilepsy/Seizure tic Panels Reference transcripts based on build GRCh37 (hg19) interrogated by Epilepsy/Seizure tic Panels Epilepsy Expanded Panel Epilepsy Expanded
More informationSubject ID: Date Test Started: Specimen Type: Peripheral Blood Date of Report: Date Specimen Obtained:
TEST PERFORMED Whole exome sequencing (WES) with Focused Diagnostic Panel(s): Neuropathy, Leukodystrophy, Myopathy See below for a complete list of genes analyzed. RESULTS 1 sequence variant with potential
More informationPromo Code (if applicable) mutation description. 1. Name of Physician. 2. Clinic. 3. Department. 4. Street. 5. Zip Code / Town. 6.
tic Diagnostics A. Analysis Requested 1. Test(s)/(s) 1.1 Single Sequencing 1.2 NGS Panel 1.3 NGS Panel Plus 1.4 NGS Panel Genomic 1.5 Deletion/Duplication Analysis B. Patient Name (Label) 1. Surname Promo
More informationMitochondrial Disorders Genetic Testing
Mitochondrial Disorders Genetic Testing A Comprehensive Guide 1 Introduction Mitochondrial disorders are a group of related, clinically diverse, genetic diseases with a prevalence of 1/5,000 to 1/8,500
More informationAnyPanel Requisition Form
AnyPanel Requisition Form Please complete every field and tick box clearly. PATIENT INFORMATION Patient s First Name Patient s Last Name Biological Sex: Male Female Unknown Gender Identity (if different
More informationNGS Panel Plus. Sequencing Sequencing + NGS based CNVs Del/Dup with MLPA. Clinic. Department. Street. ZIP Code/Town. Country. . Billing.
Promo Code (if applicable) Genetic Diagnostics (s)/gene(s)/panel(s): Analysis Requested Single Gene Sequencing Sequencing (Sanger) Sequencing (NGS) Sequencing + CNVs (with NGS) Del/Dup (MLPA or qpcr) Carrier
More informationRequisition for DNA Testing. Reason for Referral: Patient Information: INCOMPLETE REQUESTS WILL BE BANKED. Test Requests: Sample Collection:
Reason for Referral: Diagnostic Testing: Affected Unaffected Carrier testing/known Family Mutation Name of index case in the family (include copy of report): Date of Birth: Relationship to this patient:
More informationRequest for expedited Result
London Health Sciences Centre Molecular Genetics Laboratories Requisition for DNA Testing DACC002 REV 20170815 AUTHORIZED SIGNATURE IS REQUIRED INCOMPLETE REQUESTS WILL BE BANKED Molecular Genetics Laboratory
More informationTest Ordered- EPIC: Next generation sequencing(next Gen) Sunquest: NGS
UNIVERSITY OF MINNESOTA PHYSICIANS OUTREACH LABS MOLECULAR DIAGNOSTICS (612) 273-8445 DATE: TIME COLLECTED: AM PM PCU/CLINIC: DIAGNOSIS (Dx) / DIAGNOSIS CODES (ICD-9) - OUTPATIENTS ONLY (1) (2) SPECIMEN
More informationPRICE AND TEST LIST January 4, 2018 (by Test Code)
Test Code Test Description TAT Price 2018 CPT Codes WHOLE EXOME SEQUENCING WES001 MNG Exome TM Trio Sequencing and Copy Number Analysis + mtdna (Proband + 2 Family Members) 2-4 Weeks $6,900.00 81415, 81416,
More informationClinical Genomics Requisition Form
Clinical Genomics Requisition Form Please complete every field and tick box clearly. PATIENT INFORMATION Patient s First Name Patient s Last Name Biological Sex: Male Female Unknown Gender Identity (if
More informationClinical Genomics Requisition Form
Clinical Genomics Requisition Form Please complete every field and tick box clearly. PATIENT INFORMATION Patient s First Name Patient s Last Name Biological Sex: Male Female Unknown Gender Identity (if
More informationPRICE AND TEST LIST August 24, 2018 (by Test Code)
Test Code Test Description TAT Price 2018 CPT Codes WHOLE GENOME SEQUENCING WGS001 MNGenome TRIO Sequencing 2-6 Weeks Call 81425, 81426 x2 WGS003 MNGenome Proband Only Sequencing 2-6 Weeks Call 81425 WHOLE
More informationUtility of Microarrays in Molecular Genetics
Utility of Microarrays in Molecular Genetics Madhuri Hegde, Ph.D., FACMG Associate Professor Senior Director Department of Human Genetics Emory Genetics Laboratory Emory University School of Medicine Atlanta,
More informationSema4 Natalis. Clinical significance of panel. Testing methods, sensitivity, and limitations
Sema4 Natalis Clinical significance of panel Sema4 has designed and validated Natalis, a supplemental newborn screening panel offered for newborns, infants, and young children. This test may be offered
More informationNutraHacker. Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d. Instructions:
NutraHacker Carrier and Drug Response Report for Customer: b2b0b618-db91-447c-9470-ff7b79ae147d Instructions: In this report, NutraHacker examines single nucleotide polymorphisms that reveal carrier status
More informationOrdering Physician Information Additional Report Recipient 1
Test Selection Targeted Whole Exome Sequencing - Proband Only Targeted Whole Exome Sequencing - Trio Confirmatory Sanger sequencing validation Re-analysis (at least one year after initial analysis) Specimen
More informationLMM / emerge III Network Reference Sequences October 2016 LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene
LMM / emerge III Network Consensus Actionable Gene List *ACMG56 gene ACTA2* Exon 02-09 NM_001613.2 DSG2* Exon 01-15 NM_001943.3 ACTC1* Exon 01-06 NM_005159.4 DSP* Exon 01-24 NM_004415.2 APC* Exon 01-15
More informationBabyNEXT TM EXTENDED. Geni investigati e patologie associate. Gene Disease OMIM gene Familial hyperinsulinism ABCC8-related
Geni investigati e patologie associate BabyNEXT TM EXTENDED Gene Disease OMIM gene ABCC8 Familial hyperinsulinism ABCC8-related OMIM Disease Condition 600509 256450 Metabolic disorder - ABCD1 Adrenoleukodystrophy
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 09/20/2017 Date Received: 09/22/2017 Date Tested: 09/27/2017 Indication:
More informationdevseek (Sequence(Analysis(Panel(for(Neurodevelopmental(Disorders
ACSL4 Mental/retardation,/XBlinked/63 XLBR ADSL Adenylosuccinase/Deficiency AR AFF2 Mental/retardation,/XBlinked,/FRAXE/type XLBR ALG6 Congenital/disorder/of/glycosylation/type/Ic AR ANK3 Mental/retardation,/autosomal/recessive/37
More informationdevact TM Clinical Management Panel for Neurodevelopmental Disorders
Amino acid disorder AMT Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GCSH Glycine encephalopathy (non-ketotic hyperglycinemia) Amino acid disorder GLDC Glycine encephalopathy
More information4978 Santa Anita Ave Temple City, CA (p) (f)
Patient Information Doe, Jane Sex: F MR#: FD Patient#: FT-PT00000 Accession: FT-00000 Test#: FT-00000 Specimen Type: Blood (EDTA) Collection Date: Aug 01, 2017 Partner Information Not Tested Accession:
More informationEpilepsy. Genetic Test Submission Guide. 2. Samples. 1. Forms. 3. Ship RESULTS. impactgenetics.com
Epilepsy Genetic Test Submission Guide 1. Forms 2. Samples Form 1d: If applicable Form 1b: Requisition Form Form 1a: Informed Consent 3. Ship RESULTS Impact Genetics, Dynacare 4-1100 Bennett Rd. Bowmanville,
More informationMM/ DD/ YY Patient s Date of Birth
Please complete every field and tick box clearly. PATIENT INFORMATION Whole Exome Sequencing Requisition Form Patient s First Name Patient s Street Address Patient s Last Name MM/ DD/ YY Patient s Date
More informationEnabling Informed Clinical Decisions with Deep Insights. Routine Multi-gene Testing for Inherited Neuromuscular Disorders
Enabling Informed Clinical Decisions with Deep Insights Routine Multi-gene Testing for Inherited Neuromuscular Disorders Introduction Multi-gene Testing for Inherited Neuromuscular Disorders Inherited
More informationEvolve FamilyReady Carrier Screen
Evolve FamilyReady Carrier Screen Accurate & Comprehensive Expanded Carrier Screen of >200 genes for the most relevant genetic disorders for all ethnicities. Achromatopsia CNGB3 X-linked Adrenoleukodystrophy
More informationHigh Impact Treatment Benefits X-Linked Moderate Impact. Disease Gene # Mutations Disease Group(s)
CarrierMap Expanded v3 Panel: 314 Diseases CarrierMap screen for 316 diseases including DMD. Disease Groups High Impact Treatment Benefits X-Linked Moderate Impact These diseases have a significant impact
More informationLABHORIZONS. New Procedures A NEWSLETTER FOR CLIENTS
LABHORIZONS A NEWSLETTER FOR CLIENTS Volume XVII, No. 7 July 2017 New Procedures 5 HIAA, Plasma.................................. 504510 CPT 83497 Synonyms 5-hydroxyindoleacetic acid Use Plasma 5-hydroxy-indoleacetic
More informationBROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING.
BROADENING YOUR PATIENT S OPTIONS FOR GENETIC CARRIER SCREENING. The Inheritest SM Carrier Screen provides relevant genetic screening for many inherited diseases found throughout the pan-ethnic US population.
More informationGeneral Test Requisition Form - Biochemical and Molecular
General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name MM/ DD
More informationNewborn Genetic Analysis
Fulgent tics Newborn tic Analysis Newborn tic Analysis (NGA) is a highly sophisticated and sensitive genetic test that identifies DNA changes that can cause infants to develop severe or life-altering conditions.
More informationPRIMARY IMMUNODEFICIENCIES TESTING REQUISITION
MOLECULAR GENETICS LABORATORY For courier service and/or inquiries, please contact 513-636-4474 Fax: 513-636-4373 www.cincinnatichildrens.org/moleculargenetics Email: LabGeneticCounselors@cchmc.org Shipping
More informationGeneral Test Requisition Form - Biochemical and Molecular
General Test Requisition Form - Biochemical and Molecular Please complete every field and tick box clearly. PATIENT INFORMATION PATIENT SAMPLE INFORMATION Patient s First Name Patient s Last Name Middle
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: 08/17/2017 Date Received: 08/18/2017 Date Tested: 08/24/2017 Indication:
More informationResidual risks by ethnicity
Residual risks by ethnicity This table displays residual risks after a negative result for each of the genes and corresponding disorders. If a patient is reported to be a carrier of a disease, their residual
More informationCOMPLETE A FORM FOR EACH SAMPLE SUBMITTED ETHNIC BACKGROUND REPORTING INFORMATION
DATE SAMPLE DRAWN: SAMPLE TYPE: BLOOD OTHER (SPECIFY): COMPLETE A FORM FOR EACH SAMPLE SUBMITTED PATIENT FIRST NAME: LAST NAME: DOB: SEX: M F UNKNOWN ADDRESS: HOME PHONE: ( ) WORK: ( ) EUROPEAN CAUCASIAN
More informationWhole exome sequencing Gene package Epilepsy version 1,
Whole Exome Sequencing Gene package Epilepsy, version 1, 8 4 2015 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina
More informationForesight Carrier Screen
4915 25th Ave NE, Suite 204W Seattle, WA 98105 Phone: (206) 588-1484 Fax: (206) 466-4696 Sample Type: EDTA Blood Date of Collection: Date Received: 02/19/2018 Date Tested: 02/26/2018 Accession ID: CSL3P6DMJ324JJ4
More informationThe University of Chicago Genetic Services Laboratories
Aceruloplasminemia testing CP sequencing Aceruloplasminemia CP deletion/duplication Albinism testing Albinism Sequencing Panel (20 genes Albinism Deletion/Duplication Panel (20 genes Alstrom syndrome testing
More informationGenomic Service List
Document ID: MBG-C009 Effective Date: 10 Jan 018 Page: 1 of 5 WHOLE GENOME SEQUENCING Human Whole Genome Sequencing 1 HGG-15 Human Whole Genome Sequencing HGG-157 (FASTQ data only) WHOLE EXOME SEQUENCING
More informationHERES Carrier Screening TEST
LISTADO DE ENFERMEDADES ANALIZADAS HERES Carrier Screening TEST 11-Beta-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 17-Alpha-Hydroxylase Deficiency 17-Beta-Hydroxysteroid Dehydrogenase 3 Deficiency
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: EDTA Blood Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:
More informationCentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION
CentoCancer STRIVE FOR THE MOST COMPLETE INFORMATION CentoCancer our most comprehensive oncogenetics panel for hereditary mutations Hereditary pathogenic variants confer an increased risk of developing
More informationWhole exome sequencing Gene package Epilepsy version 2,
Whole Exome Sequencing Gene package Epilepsy, version 2, 1 7 2017 Technical information After DNA was enriched using Agilent Sureselect Clinical Research Exome (CRE) Capture, samples were run on the Illumina
More informationCHRONIC MYELOGENOUS LEUKEMIA
CHRONIC MYELOGENOUS LEUKEMIA SHUFFLING THE GENETIC DECK IN CML 9 9 (q+) 22 Ph (22q-) bcr bcr-abl abl Fusion protein causes cancer GLEEVEC AND BCR-ABL FUSION PROTEIN GENETIC MEDICINE A. Genetic diseases
More informationLions and Tigers and Bears.Oh My!
Lions and Tigers and Bears.Oh My! TAKING THE FEAR OUT OF GENETIC TESTING Lisa Butterfield, MS, CGC Genetic Counselor Clinical Assistant Professor University of Kansas Health System Why is Genetic Testing
More informationDiagnose a broad range of metabolic disorders with a single test, Global MAPS
PEDIATRIC Assessing or diagnosing a metabolic disorder commonly requires several tests. Global Metabolomic Assisted Pathway Screen, commonly known as Global MAPS, is a unifying test for analyzing hundreds
More informationSupplemental Figure 1
Supplemental Figure 1 mir 26a mir 26b Supplemental Figure 1. Expression of mir-26a is higher than mir-26b in the mouse liver. Dot blot analysis of mir-26a/b expression in the livers of wild-type mice fed
More informationJoshua Hellmann Foundation - Newborn Metabolic Screening Program
Joshua Hellmann Foundation - Newborn Metabolic Screening Program Centre of Inborn Errors of Metabolism The Chinese University of Hong Kong Last update: 11 June 2013 Target inborn errors of metabolism (IEM)
More informationDivision of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition.
Page 1 of 8 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostics Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 PATIENT
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 07/12/2017 Date Received: 07/17/2017 Date Tested: 07/17/2017 Indication:
More informationForesight Carrier Screen
Freiburg Medical Laboratory, ME LLC Box 3068 Dubai, 00000 Phone: +971 4 396 2227 FE Sample Type: EDTA Blood Date of Collection: 04/23/2018 Date Received: 04/27/2018 Date Tested: 05/05/2018 Indication:
More informationPatient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:
PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:
More informationWhole exome sequencing Gene package Epilepsy version 3,
Whole Exome Sequencing Gene package Epilepsy, version 3, 1 2 2018 Technical information DNA was enriched using Agilent SureSelect Clinical Research Exome V2 capture and paired end sequenced on the Illumina
More informationCARRIER SCREENING PANEL
1 / 6 1. WHAT IS THE CARRIER? The carrier screening panel is a genetic test that simultaneously analyses mutations in 298 genes which cause recessive inherited pathologies. Diseases with a recessive inheritance
More informationAccount # Notes. Physician Name Physician Phone Fax. Diagnosis. CLIA #38D Q11 REQ page 1 of 5
Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Molecular Genetics Test Requisition
More informationA Targeted Next Generation Sequencing (tngs) Screening Assay for Menkes Disease and its Implications for Primary DNA-based Newborn Screening
A Targeted Next Generation Sequencing (tngs) Screening Assay for Menkes Disease and its Implications for Primary DNA-based Newborn Screening Richard B. Parad 1, Stephen G. Kaler 2, Evan Mauceli 4, Tanya
More informationSAMPLE. Carrier Screening Results Report v2.2 Page 1/8
MM480: Pan-Ethnic Carrier Screen - Targeted Mutation Panel Report Prepared For: Patient: Name: Date of Birth: IDs (Internal / External): Reported Gender: Reported Ethnicity: Sample: Sample Collection Date:
More informationPresentation and investigation of mitochondrial disease in children
Presentation and investigation of mitochondrial disease in children Andrew Morris Willink Unit, Manchester Mitochondrial function Carbohydrate Fat Respiratory chain Energy Mitochondria are the product
More informationNeurodegenerative disorders: an approach to investigation. Robert Robinson Practical Paediatric Neurology Study Days April 2018
Neurodegenerative disorders: an approach to investigation Robert Robinson Practical Paediatric Neurology Study Days April 2018 Aims An approach to investigating and diagnosing young children with progressive
More informationAnalysis and interpretation of genetic NEUROLOGICAL DISORDERS
, PH 1, POLG M, RAPSN, R CA, SGCB, SGC A3, SLC25A4, SLC5 1, SYNE2, SYT2, TAC NNT1, TNNT3, T N 4, TRIM63, TRIP4, AS39, VMA21, VPS S, ACADVL, ACTA1, AD 1, ANO5, ASCC1, ATP2A CACNA1S, CAPN3, CASQ P1, COL12A1,
More informationThe circulating T helper subsets and regulatory T cells in patients with common variable immunodeficiency with no monogenic disease
1 Supplementary data The circulating T helper subsets and regulatory T cells in patients with common variable immunodeficiency with no monogenic disease Azizi et al. 2 Table S1. Excluded 373 genes variants
More informationREQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First
#: DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS & SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax#: 212-305-3986 REQUISITION FORM NOTE: ALL FORMS MUST
More informationNEXT GENERATION SANGER SEQUENCING PLATFORMS (NGS)
NEXT GENERATION SANGER SEQUENCING PLATFORMS (NGS) Category Disease Category Disease Number of Genes Genes Comment Test Specification Price in Next Generation and Sanger Sequencing Platforms (NGS) Cancer
More informationAll diseases on Foresight
All diseases on Foresight Disease 11-Beta-Hydroxylase- Deficient Congenital Adrenal Hyperplasia 21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia 3-Hydroxy-3-Methylglutaryl- CoA Lyase Deficiency
More informationIntellectual Disability Exome Panel Requisition Form
Intellectual Disability Exome Panel Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local:
More informationForesight Carrier Screen
321 Main Street San Francisco, CA 94080 Phone: (415) 555-5555 Fax: (415) 555-5555 FE Sample Type: OG-510 Saliva Date of Collection: 06/23/2017 Date Received: 06/28/2017 Date Tested: 06/28/2017 Indication:
More informationAnnotation SNPEff_ Annotation SNPEff_. SNPEff_. Annotation. SNPEff_. Annotation. SNPEff_. Annotation. SNPEff_. Annotation
Chr Gene p-value Binned_ variants Phenotype Biological_Feature Note 11 DRD2 0.001179727 35 Asthma Gene 16 CES2 0.010970381 40 Asthma Gene 19 LDLR 0.023074213 43 Asthma Gene 10 ARID5B 0.025870289 44 Asthma
More informationPatient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone. the hospital/facility:
PATIENT INFORMATION (COMPLETE ONE FORM FOR EACH PERSON TESTED) Patient Last Name Patient First Name MI Date of Birth (MM / DD / YYYY) Address City State Zip Phone Patient discharged from Biological Sex:
More informationExome Requisition Form
Patient Information Exome Requisition Form The University of Chicago Genetic Services Laboratories 5841 South Maryland Avenue, Room G701/MC0077, Chicago, IL 60637 Toll Free: 888.824.3637 Local: 773.834.0555
More informationReferring Physician Information Name: (Last, First, Middle):
Page 1 of 5 Patient Information Clinical Indication: Patient Name: (Last, First, Middle): DOB (M/D/Y): Sex: M F Guardian Name (for minor patients only): Address: City: State: ZIP: Phone: Ethnic Background
More informationPANELES PARA ESTUDIOS GENÉTICOS
PANELES PARA ESTUDIOS GENÉTICOS Ante cualquier duda o consulta, puede escribirnos a: estudiosgeneticos@labmedicina.com EXÁMENES PARA CÁNCER HEREDITARIO Panel de Cáncer Hereditario - Principales Genes (37
More informationMetBioNet Best Practice Guidelines. Investigation of an inherited metabolic cause of cardiomyopathy
Introduction MetBioNet Best Practice Guidelines Investigation of an inherited metabolic cause of Inborn errors of metabolism (IEM) account for at least 5% of cases of. In some disorders, is the major cause
More informationA. disorders of amino acid metabolism classical phenylketonuria and hyperphenylalaninemia
OMIM # FULL NAME A. disorders of amino acid metabolism 1 261600 classical phenylketonuria and hyperphenylalaninemia 2 261640 phenylketonuria due to PTPS deficiency 3 261630 phenylketonuria due to DHPR
More informationDivision of Genomic Diagnostics GENOMIC DIAGNOSTICS TEST REQUISITION *For Cancer tests please use the Cancer Test Requisition.
Page 1 of 10 SHIP TO: Children s Hospital of Philadelphia, Genomic Diagnostics Laboratory, 3615 Civic Center Blvd., Abramson Research Center, 714, Philadelphia, PA 19104-4302 - Phone: (215) 590-4452 Patient
More informationNovel mutation of type 1 insulin-like growth factor receptor (IGF1R) gene in a severe short stature pedigree identified by targeted
Research Article Novel mutation of type 1 insulin-like growth factor receptor (IGF1R) gene in a severe short stature pedigree identified by targeted next-generation sequencing Running title: Novel mutation
More informationClinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing
Yonago Acta medica 2016;59:118 125 Original Article Clinical Diagnosis of Mendelian Disorders Using a Comprehensive Gene-Targeted Panel Test for Next-Generation Sequencing Tetsuya Okazaki,* Megumi Murata,
More informationMaturity-onset diabetes of the young (MODY) is a heterogeneous group
Over the years, different forms of maturity-onset diabetes of the young (MODY) have been identified, with mutations in a number of different genes associated with a MODY-like phenotype. Depending on the
More informationSpieraandoeningen genpanel v2 (148 genen)
Spieraandoeningen genpanel v2 (148 genen) Gene ACADVL 99,8 VLCAD deficiency, 201475 ACTA1 99,1 Nemaline myopathy 3, autosomal dominant or recessive, 161800 Myopathy, actin, congenital, with excess of thin
More informationInformed Consent Columbia Whole Genome or Whole Exome Sequencing
Informed Consent Columbia Whole Genome or Whole Exome Sequencing Please read the following form carefully and discuss with your ordering physician before signing consent. This consent is intended for the
More informationCentoXome FUTURE'S KNOWLEDGE APPLIED TODAY
CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY More genetic information requires cutting-edge interpretation techniques Whole Exome Sequencing For certain patients the combination of symptoms does not allow
More informationNewborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis)
Newborn Screen & Development Facts about the genetic diseases new since March 2006 (Excluding Cystic Fibrosis) 1) Argininosuccinic acidemia (ASA) a) Incidence: ~1 in 70,000 b) Deficiency in an enzyme of
More informationCentoXome FUTURE'S KNOWLEDGE APPLIED TODAY
CentoXome FUTURE'S KNOWLEDGE APPLIED TODAY More genetic information requires cutting-edge interpretation techniques Whole Exome Sequencing For some patients, the combination of symptoms does not allow
More informationN.I.R.M.A.N. Dr. ANIL B. JALAN (MD DCH MCPS) Test list Oct 2017
Tests and Profiles Tests Method Sample Needed TAT Genetic Consultation / - All samples to be sent at 2 8 C. Counseling 1 Urine MRST - 15 ml Urine 24 hrs 2 Sr. Ammonia, Lactate, Sugar Fuji Dry Chem 2 ml
More informationQuick Guide To Genetic Testing
Aceruloplasminemia testing CP sequencing 2101 81406 4 weeks $1,000 Aceruloplasminemia CP deletion/duplication 2102 81405 4 weeks $1,000 Albinism testing Albinism Sequencing ** 1101 81407 8 weeks $2,500
More information# DISEASE GENE GHI CHÚ 1 17-beta-hydroxysteroid dehydrogenase defciency, type HSD17B Hydroxy-3-methylglutaryl-CoA lyase deficiency HMGCL
# DISEASE GENE GHI CHÚ 1 17-beta-hydroxysteroid dehydrogenase defciency, type HSD17B3 III 2 3-Hydroxy-3-methylglutaryl-CoA lyase HMGCL 3 3-hydroxyacyl-CoA dehydrogenase defciency HADH 4 3-hydroxyisobutryl-CoA
More informationSummary. Syndromic versus Etiologic. Definitions. Why does it matter? ASD=autism
Summary It is becoming clear that multiple genes with complex interactions underlie autism spectrum (ASD). A small subset of people with ASD, however, actually suffer from rare single-gene Important to
More informationFurther expansion of the neonatal screening panel in the Netherlands
Further expansion of the neonatal screening panel in the Netherlands J.Gerard Loeber APHL-NBSGT, St.Louis (MO), USA 290216 Population Area Newborns 6.01 million 0.35:1 16.8 million 180,693 sq km 4.3:1
More informationOXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018
OXFORD MEDICAL GENETICS LABORATORIES CURRENT DISEASE SERVICES APRIL 2018 Please note that there is a 15% surcharge for Non-NHS patients. Highly specialised services (HSS) are indicated. Note: This test
More informationtheraseek Panel Gene List by Category
theraseek Panel Gene List by Category Gene Pathway/Function Association ACAT1 Alpha-methylacetoacetic aciduria Amino acid metabolism Pathway DHTKD1 Charcot-Marie-Tooth disease 2Q, axonal/2-aminoadipic
More informationSCOPE OF ACCREDITATION TO ISO 15189:2012. PREVENTION GENETICS 3800 S. Business Park Ave. Marshfield, WI Jessica Kayhart Phone:
SCOPE OF ACCREDITATION TO ISO 15189:2012 PREVENTION GENETICS 3800 S. Business Park Ave. Marshfield, WI 54449 Jessica Kayhart Phone: 715 387 0484 CLINICAL Valid To: September 30, 2018 Certificate Number:
More informationGENE BY GENE CARRIER SCREENING
Patient Copy GENE BY GENE CARRIER SCREENING GENE BY GENE CARRIER SCREEN Various genetic mutations occur with increased frequencies in various ethnic groups in the United States and around the world. For
More informationIllumina Clinical Services Laboratory
Illumina Clinical Services Laboratory CLIA Certificate No.: 05D1092911 Illumina Clinical Services Laboratory TruGenome Predisposition Screen Requisition Form The TruGenome Predisposition Screen is intended
More informationRoutine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015
Routine Newborn Screening, Testing the Newborn Inherited Metabolic Disorders Update August 2015 Metabolic birth defects can cause physical problems, mental retardation and, in some cases, death. It is
More informationMolecular Genetics Requisition Form 2. Clinical Whole Exome Sequencing Informed Consent 5. Clinical Whole Exome Sequencing Information & FAQ 12
NYGC CLINICAL WHOLE EXOME SEQUENCING Phone: 646-697-7106 Fax: 347-875-4100 Email: Clinical@nygenome.org TABLE OF CONTENTS Molecular Genetics Requisition Form 2 Clinical Whole Exome Sequencing Informed
More informationKnight Diagnostic Laboratories. Exome Requisition for Proband. Complete Exome Orders Must Include All of the Following:
Knight Diagnostic Laboratories Fax: (855) 535-1329 Email: KDLClientServices@ohsu.edu Shipping: 2525 SW 3rd Ave, Ste 350, Portland, OR 97201 Questions? (855) 535-1522 Exome Requisition for Proband Complete
More informationFor Your Baby s Health Department of Health
Newborn Screening For Your Baby s Health Department of Health Why is my baby tested? To help make sure your baby will be as healthy as possible. The blood test provides important information about your
More information